newsfilter
← Latest News
GlobeNewswire·

180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren's Disease

PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), today announced the publication of a review entitled ‘Dupuytren's disease: a localized